Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study

Citation
Fa. Bu'Lock et al., Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study, PEDIAT CARD, 20(4), 1999, pp. 252-263
Citations number
35
Categorie Soggetti
Pediatrics
Journal title
PEDIATRIC CARDIOLOGY
ISSN journal
01720643 → ACNP
Volume
20
Issue
4
Year of publication
1999
Pages
252 - 263
Database
ISI
SICI code
0172-0643(199907/08)20:4<252:LVDFPA>2.0.ZU;2-B
Abstract
The objective of this study was to examine changes in diastolic function as sociated with progressive myocardial damage and their implications. We used prospective sequential Doppler echocardiographic studies of left ventricul ar (LV) function. The study included 125 consecutive children (median age 6 .3 years) receiving anthracyclines to cumulative doses between 45 and 1150 mg/m(2) (median 270 mg/m(2)). We measured peak early (E) and atrial (A) pha se filling velocities, EA ratio, deceleration and isovolumic relaxation tim es (EDecT and IVRT), heart rate, and fractional shortening (SF). Results we re compared serially and with individually paired control data matched for body surface area. Progressive myocardial damage was evidenced by a mean SF decrease of 1 absolute %/100 mg/m(2) of anthracycline. Six patients develo ped cardiac failure. After 1-100 mg/m(2) of anthracyclines, the EA ratio de creased (mean 1.54-1.40, p = 0.02) and IVRT became prolonged (54 vs 52 msec in controls, p = 0.03). EA ratio increased again with the next dose, usual ly normalizing thereafter. Twelve patients ended treatment with an EA ratio <1 (1 cardiac death) and 17 with EA ratio >2 (2 cardiac deaths). Diastolic abnormalities were not strongly predictive of reduced SF. Modest changes i n left ventricular diastolic filling patterns occur during anthracycline tr eatment of childhood malignancies. Although 20% of patients have significan t abnormalities of diastolic filling by the end of treatment, considerable individual variability renders the pathophysiological and clinical implicat ions of the early changes uncertain.